AtaCor Medical Announces First Patient Treated Globally in its ALARION-EV Pivotal Trial

AtaCor Medical Announces First Patient Treated Globally in its ALARION-EV Pivotal Trial

Study will evaluate AtaCor's investigational Atala™ lead in conjunction with Abbott's investigational EV-ICD pulse generatorStudy will evaluate a novel parasternal extravascular ICD approach for the treatment of life-threatening ventricular tachyarrhythmias

First patient enrolled in AtaCor’s ALARION-EV trial of EV-ICD system

AtaCor Medical has enrolled the first patient in its ALARION-EV pivotal trial, which is evaluating an investigational EV-ICD system.The post First patient enrolled in AtaCor’s ALARION-EV trial of EV-ICD system appeared first on Hospital Management.